Just an opinion here, but consider that there are a lot of trials going on. Some of the eligible patients may be involved with something else first. We get the failures from a much smaller subset of the sick patients, maybe. Or consider that, just like this forum, some people have very strong opinions of the worth of other treatments and doctors are no different. They’re in the middle of a sh*t storm and there’s not a lot of time to learn about a brand new treatment option while desperately trying to keep people from dying. The “unknown” new things like Leronlimab aren’t super easy to implement on the fly. I think the good news out of this is how Leronlimab is showing it’s effect in a very important population where no other “new” option is testing, meaning the sickest of sick with comorbidities and organ failure. It’ll take longer but be more impossible to ignore. I’m frustrated too. You’d have thought it would have spread like a wildfire via word of mouth. There’s just a LOT of other factors and plenty of red tape/timing issues that make it difficult. Getting consent, hospital and fda authorizations in place, getting the actual vials in your hands, and on and on. It sucks but I think we’re still poised to make a major impact in 2-4 weeks when hopefully there’s enough information for the FDA to stop our trial(s) and approve Leronlimab. My fingers are crossed so hard they’ve long since gone numb.